Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising effects. However, the price of this innovative drug and its availability have become key topics for patients and healthcare providers. While tirzepatide has been cleared by regulatory agencies, its costly nature presents a significant challenge to many. Neg